METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.

CONCLUSION: METS-IR is a novel score to evaluate cardiometabolic risk in healthy and at-risk subjects and a promising tool for screening of insulin sensitivity.
PMID: 29535168 [PubMed - as supplied by publisher]

Source: European Journal of Endocrinology - March 13, 2018 Category: Endocrinology Authors: Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, Sánchez-Lázaro D, Meza-Oviedo D, Vargas-Vazquez A, Arellano Campos O, Sevilla-González MDR, Martagón AJ, Muñoz Hernández L, Mehta RP, Caballeros-Barra Tags: Eur J Endocrinol Source Type: research